Preventive IVIG Therapy for Congenital Heart Block (PITCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00460928

Recruitment Status : Completed

First Posted : April 17, 2007

Last Update Posted : September 30, 2019

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Lupus Research Alliance

Information provided by (Responsible Party):

NYU Langone Health

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	June 2009
Actual Study Completion Date :	June 2009

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Friedman DM, Llanos C, Izmirly PM, Brock B, Byron J, Copel J, Cummiskey K, Dooley MA, Foley J, Graves C, Hendershott C, Kates R, Komissarova EV, Miller M, Pare E, Phoon CK, Prosen T, Reisner D, Ruderman E, Samuels P, Yu JK, Kim MY, Buyon JP. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010 Apr;62(4):1138-46. doi: 10.1002/art.27308.

To Top